Shopping Cart 0
Cart Subtotal
USD 0

Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 525
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Regeneron Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Regeneron Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Regeneron Pharmaceuticals (Regeneron or 'the company') is a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines. The company primarily operates in the US, where it is headquartered in New York, and employed 2,925 people as on December 31, 2014.

Scope

- Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Regeneron Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Regeneron Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Regeneron Pharmaceuticals, Inc.: Company Overview 9

Regeneron Pharmaceuticals, Inc.: Overview and Key Facts 9

Regeneron Pharmaceuticals, Inc.: Overview 9

Regeneron Pharmaceuticals, Inc.: Key Facts 9

Regeneron Pharmaceuticals, Inc.: Key Employees 11

Regeneron Pharmaceuticals, Inc.: Key Employee Biographies 13

Regeneron Pharmaceuticals, Inc.: Major Products and Services 22

Regeneron Pharmaceuticals, Inc.: Company History 24

Regeneron Pharmaceuticals, Inc.: Management Statement 30

Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries 32

Regeneron Pharmaceuticals, Inc.: Key Competitors 33

Regeneron Pharmaceuticals, Inc.: Company Analysis 34

Regeneron Pharmaceuticals, Inc.: Business Description 34

Regeneron Pharmaceuticals, Inc.: SWOT Analysis 36

Regeneron Pharmaceuticals, Inc.: SWOT Overview 36

Regeneron Pharmaceuticals, Inc.: Strengths 36

Regeneron Pharmaceuticals, Inc.: Weaknesses 37

Regeneron Pharmaceuticals, Inc.: Opportunities 38

Regeneron Pharmaceuticals, Inc.: Threats 39

Regeneron Pharmaceuticals, Inc.: Corporate Financial Deals Activity 41

Regeneron Pharmaceuticals, Inc.: Financial Deals Overview 41

Regeneron Pharmaceuticals, Inc.: Targets and Partners 43

Regeneron Pharmaceuticals, Inc.: Top Deals 2014-2018YTD* 45

Regeneron Pharmaceuticals, Inc.: Advisors 46

Regeneron Pharmaceuticals, Inc.: Top Legal Advisors 46

Regeneron Pharmaceuticals, Inc.: Corporate Venturing 47

Regeneron Pharmaceuticals, Inc.: Partnership 48

Regeneron Pharmaceuticals, Inc.: Recent Developments 49

Regeneron Pharmaceuticals, Inc.: News and Events Summary 49

Regeneron Pharmaceuticals, Inc.: Contracts 52

Regeneron Pharmaceuticals, Inc.: Corporate Governance 53

Regeneron Pharmaceuticals, Inc.: Financial Performance 53

Regeneron Pharmaceuticals, Inc.: Grants 54

Regeneron Pharmaceuticals, Inc.: Market Developments 54

Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events 55

Regeneron Pharmaceuticals, Inc.: Research & Development 56

Regeneron Pharmaceuticals, Inc.: Strategy and Operations 57

Appendix 58

Contact Us 58

Methodology 58

About MarketLine 59


List Of Figure

List of Figures

Figure 1: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 3: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Figure 4: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Figure 5: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 6: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Regeneron Pharmaceuticals, Inc.: Key Facts

Table 2: Regeneron Pharmaceuticals, Inc.: Key Employees

Table 3: Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Regeneron Pharmaceuticals, Inc.: Key Competitors

Table 5: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 7: Regeneron Pharmaceuticals, Inc.: Targets and Partners

Table 8: Regeneron Pharmaceuticals, Inc.: Top Deals 2014-2018YTD*

Table 9: Regeneron Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (USUSDm)

Table 10: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Table 11: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Table 12: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 13: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 14: Regeneron Pharmaceuticals, Inc.: News and Events Summary

Table 15: Regeneron Pharmaceuticals, Inc.: Contracts

Table 16: Regeneron Pharmaceuticals, Inc.: Corporate Governance

Table 17: Regeneron Pharmaceuticals, Inc.: Financial Performance

Table 18: Regeneron Pharmaceuticals, Inc.: Grants

Table 19: Regeneron Pharmaceuticals, Inc.: Market Developments

Table 20: Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 21: Regeneron Pharmaceuticals, Inc.: Research & Development

Table 22: Regeneron Pharmaceuticals, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Regeneron Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Regeneron Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Regeneron Pharmaceuticals (Regeneron or 'the company') is a science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines. The company primarily operates in the US, where it is headquartered in New York, and employed 2,925 people as on December 31, 2014.

Scope

- Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Regeneron Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Regeneron Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Regeneron Pharmaceuticals, Inc.: Company Overview 9

Regeneron Pharmaceuticals, Inc.: Overview and Key Facts 9

Regeneron Pharmaceuticals, Inc.: Overview 9

Regeneron Pharmaceuticals, Inc.: Key Facts 9

Regeneron Pharmaceuticals, Inc.: Key Employees 11

Regeneron Pharmaceuticals, Inc.: Key Employee Biographies 13

Regeneron Pharmaceuticals, Inc.: Major Products and Services 22

Regeneron Pharmaceuticals, Inc.: Company History 24

Regeneron Pharmaceuticals, Inc.: Management Statement 30

Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries 32

Regeneron Pharmaceuticals, Inc.: Key Competitors 33

Regeneron Pharmaceuticals, Inc.: Company Analysis 34

Regeneron Pharmaceuticals, Inc.: Business Description 34

Regeneron Pharmaceuticals, Inc.: SWOT Analysis 36

Regeneron Pharmaceuticals, Inc.: SWOT Overview 36

Regeneron Pharmaceuticals, Inc.: Strengths 36

Regeneron Pharmaceuticals, Inc.: Weaknesses 37

Regeneron Pharmaceuticals, Inc.: Opportunities 38

Regeneron Pharmaceuticals, Inc.: Threats 39

Regeneron Pharmaceuticals, Inc.: Corporate Financial Deals Activity 41

Regeneron Pharmaceuticals, Inc.: Financial Deals Overview 41

Regeneron Pharmaceuticals, Inc.: Targets and Partners 43

Regeneron Pharmaceuticals, Inc.: Top Deals 2014-2018YTD* 45

Regeneron Pharmaceuticals, Inc.: Advisors 46

Regeneron Pharmaceuticals, Inc.: Top Legal Advisors 46

Regeneron Pharmaceuticals, Inc.: Corporate Venturing 47

Regeneron Pharmaceuticals, Inc.: Partnership 48

Regeneron Pharmaceuticals, Inc.: Recent Developments 49

Regeneron Pharmaceuticals, Inc.: News and Events Summary 49

Regeneron Pharmaceuticals, Inc.: Contracts 52

Regeneron Pharmaceuticals, Inc.: Corporate Governance 53

Regeneron Pharmaceuticals, Inc.: Financial Performance 53

Regeneron Pharmaceuticals, Inc.: Grants 54

Regeneron Pharmaceuticals, Inc.: Market Developments 54

Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events 55

Regeneron Pharmaceuticals, Inc.: Research & Development 56

Regeneron Pharmaceuticals, Inc.: Strategy and Operations 57

Appendix 58

Contact Us 58

Methodology 58

About MarketLine 59


List Of Figure

List of Figures

Figure 1: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 3: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Figure 4: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Figure 5: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 6: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Regeneron Pharmaceuticals, Inc.: Key Facts

Table 2: Regeneron Pharmaceuticals, Inc.: Key Employees

Table 3: Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Regeneron Pharmaceuticals, Inc.: Key Competitors

Table 5: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 6: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 7: Regeneron Pharmaceuticals, Inc.: Targets and Partners

Table 8: Regeneron Pharmaceuticals, Inc.: Top Deals 2014-2018YTD*

Table 9: Regeneron Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (USUSDm)

Table 10: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD*2018)

Table 11: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD*2018)

Table 12: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 13: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 14: Regeneron Pharmaceuticals, Inc.: News and Events Summary

Table 15: Regeneron Pharmaceuticals, Inc.: Contracts

Table 16: Regeneron Pharmaceuticals, Inc.: Corporate Governance

Table 17: Regeneron Pharmaceuticals, Inc.: Financial Performance

Table 18: Regeneron Pharmaceuticals, Inc.: Grants

Table 19: Regeneron Pharmaceuticals, Inc.: Market Developments

Table 20: Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 21: Regeneron Pharmaceuticals, Inc.: Research & Development

Table 22: Regeneron Pharmaceuticals, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com